# Peraso Inc.: overview PRSO · Nasdaq · CIK 890394 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/prso.md) · [Financials](/companies/prso/financials.md) · [Filings](/companies/prso/filings.md) · [Insiders](/companies/prso/insiders.md) Latest reported revenue: [$1.3m](/filings/0001213900-26-089119.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-089119). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [3,841](/filings/0001213900-24-097140.md) | [3,678 d](/filings/0001013762-25-004082.md) | [3,869](/filings/0001213900-26-056603.md) | [2,220](/filings/0001213900-26-089119.md) | [3,234](/filings/0001213900-25-108587.md) | [2,870 d](/filings/0001213900-26-036514.md) | [963](/filings/0001213900-26-056603.md) | [1,307](/filings/0001213900-26-089119.md) | | Gross margin | % | [47.0%](/filings/0001213900-25-108587.md) | [56.3% d](/filings/0001213900-26-036514.md) | [69.3%](/filings/0001213900-26-056603.md) | [48.3%](/filings/0001213900-26-089119.md) | [56.2%](/filings/0001213900-25-108587.md) | [52.2% d](/filings/0001213900-26-036514.md) | [61.5%](/filings/0001213900-26-056603.md) | [63.7%](/filings/0001213900-26-089119.md) | | Operating margin | % | [(70.3%)](/filings/0001213900-25-108587.md) | [(44.3%) d](/filings/0001213900-26-036514.md) | [(13.3%)](/filings/0001213900-26-056603.md) | [(80.0%)](/filings/0001213900-26-089119.md) | [(36.8%)](/filings/0001213900-25-108587.md) | [(44.6%) d](/filings/0001213900-26-036514.md) | [(257.9%)](/filings/0001213900-26-056603.md) | [(171.1%)](/filings/0001213900-26-089119.md) | | Net margin | % | [(70.6%)](/filings/0001213900-25-108587.md) | [(42.4%) d](/filings/0001213900-26-036514.md) | [(12.2%)](/filings/0001213900-26-089119.md) | [(82.4%)](/filings/0001213900-26-089119.md) | [(37.4%)](/filings/0001213900-25-108587.md) | [(43.3%) d](/filings/0001213900-26-036514.md) | [(259.3%)](/filings/0001213900-26-089119.md) | [(169.9%)](/filings/0001213900-26-089119.md) | | Diluted EPS | $ per share | [(0.98)](/filings/0001213900-25-108587.md) | not reported | [(0.08)](/filings/0001213900-26-056603.md) | [(0.31)](/filings/0001213900-26-089119.md) | [(0.17)](/filings/0001213900-25-108587.md) | not reported | [(0.22)](/filings/0001213900-26-056603.md) | [(0.16)](/filings/0001213900-26-089119.md) | | Free cash flow | $k | not reported | not reported | not reported | not reported | [(1,582) d](/filings/0001213900-25-108587.md) | [(1,083) d](/filings/0001213900-26-036514.md) | [(2,532)](/filings/0001213900-26-056603.md) | [(1,671) d](/filings/0001213900-26-089119.md) | - Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [5.7](/filings/0001564590-22-012981.md) | [14.9](/filings/0001213900-24-027971.md) | [13.7](/filings/0001213900-24-027971.md) | [14.6](/filings/0001013762-25-004082.md) | [12.2](/filings/0001213900-26-036514.md) | | Gross margin | % | [42.4%](/filings/0001213900-23-024118.md) | [40.0%](/filings/0001213900-24-027971.md) | [13.6%](/filings/0001013762-25-004082.md) | [51.7%](/filings/0001213900-26-036514.md) | [58.0%](/filings/0001213900-26-036514.md) | | Operating margin | % | [(283.1%)](/filings/0001213900-23-024118.md) | [(217.3%)](/filings/0001213900-24-027971.md) | [(150.0%)](/filings/0001013762-25-004082.md) | [(85.3%)](/filings/0001213900-26-036514.md) | [(39.0%)](/filings/0001213900-26-036514.md) | | Net margin | % | [(192.1%)](/filings/0001213900-23-024118.md) | [(217.9%)](/filings/0001213900-24-027971.md) | [(122.2%)](/filings/0001013762-25-004082.md) | [(73.6%)](/filings/0001213900-26-036514.md) | [(39.0%)](/filings/0001213900-26-036514.md) | | Diluted EPS | $ per share | [(1.86)](/filings/0001213900-23-024118.md) | [(64.41)](/filings/0001213900-24-027971.md) | [(26.00)](/filings/0001013762-25-004082.md) | [(3.57)](/filings/0001213900-26-036514.md) | [(0.67)](/filings/0001213900-26-036514.md) | | Free cash flow | $m | [(12.1)](/filings/0001213900-23-024118.md) | [(17.0)](/filings/0001213900-24-027971.md) | [(4.8)](/filings/0001013762-25-004082.md) | not reported | [(5.7)](/filings/0001213900-26-036514.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/prso/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $108.5k | 119,343 | | Added +19,752 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $88.9k | 97,828 | | Added +53,986 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $82.6k | 90,838 | | Unchanged | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $52.7k | 57,965 | | Unchanged | | [StoneX Group Inc.](/funds/913760.md) | 2026-06-30 | $29.0k | 30,209 | | New +30,209 | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $27.4k | 30,148 | | Added +9,793 | | [XTX Topco Ltd](/funds/1828301.md) | 2026-06-30 | $18.3k | 20,186 | | New +20,186 | | [Annis Gardner Whiting Capital Advisors, LLC](/funds/1998414.md) | 2026-06-30 | $9.2k | 10,102 | | Unchanged | | [Kestra Advisory Services, LLC](/funds/1830819.md) | 2026-06-30 | $9.1k | 10,000 | | Unchanged | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $3.8k | 4,186 | | Reduced −3,694 | ## Recent filings [All 814 filings](/companies/prso/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-11 | 16:30 ET | [8-K](/filings/0001213900-26-099297.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-099297 | | 2026-08-21 | 17:30 ET | [8-K](/filings/0001213900-26-092719.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-092719 | | 2026-08-13 | 16:16 ET | [10-Q](/filings/0001213900-26-089119.md) | Quarterly report, period 2026-06-30 | 0001213900-26-089119 | | 2026-08-11 | 16:32 ET | [8-K](/filings/0001654954-26-007474.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-007474 | | 2026-08-10 | 08:30 ET | [DEF 14A](/filings/0001213900-26-086972.md) | Proxy statement, period 2026-09-10 | 0001213900-26-086972 | | 2026-07-29 | 17:27 ET | [8-K](/filings/0001213900-26-082911.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-082911 | | 2026-07-24 | 17:00 ET | [8-K](/filings/0001213900-26-081466.md) | 3.01 Delisting notice; 5.08 Item not in the standard list | 0001213900-26-081466 | | 2026-07-10 | 16:45 ET | [8-K](/filings/0001213900-26-077192.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-077192 | | 2026-07-02 | 17:26 ET | [S-1](/filings/0001213900-26-075105.md) | Registration statement | 0001213900-26-075105 | | 2026-07-02 | 17:13 ET | [8-K](/filings/0001213900-26-075082.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-075082 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-036514.md), filed Mar 30, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/8ff9d271-8b9e-424c-8570-3a314e4c5d37) ## About the filer - CIK: 890394 - Tickers: PRSO - Exchange: Nasdaq - SIC code: 3674 Semiconductors & Related Devices - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 09:06 ET. No prices; not investment advice.